SCHEDULE 13G/A

Unicycive Therapeutics, Inc.

Common Stock, $0.001 par value · CUSIP: 90466Y202

Event date: 2025-09-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Octagon Capital Advisors LP

  Shares: 1,000,000.00 · Class: 5.7%

• Octagon Investments Master Fund LP

  Shares: 650,000.00 · Class: 3.7%

• Octagon Private Opportunities Fund II LP

  Shares: 350,000.00 · Class: 2.0%

• Ting Jia

  Shares: 1,000,000.00 · Class: 5.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.